HIGHLY TIME SENSITIVE BUY ALERT:
Advance Notification from Tim Fields,
Editor In Chief, Untapped Wealth

“At $4, this is a dream stock at a bargain price that could be
the most profitable investment of your entire lifetime. Even the
 federal government says the Genetic Diagnostics industry
‘PROMISES TO REVOLUTIONIZE MEDICINE.’

ACTION TO TAKE RIGHT NOW:
Buy shares of our #1 Diagnostics Stock in the
 $4 range and watch your $5,000 investment rise
 to $16,250 or more.

     When you read this letter, you’ll see why I say this dynamic stock can prosper and soar even in today’s down-in-the-dumps markets.  

Because I’ve just uncovered one of the most exciting stocks I’ve ever found…

     I’m stunned that it’s just $4 a share.

I thought there was a misprint in Investor’s Business Daily when I checked it.

This stock is practically invisible on Wall Street. I’d be surprised if one out of 700 brokers ever heard of it. Investors don’t know it exists. Financial shows pass it by. It’s completely off the radar screen of the big investment houses.

I promise you this: a small group of investors who act now because they realize what’s at stake have the opportunity to grow rich or so close to being rich, it won’t make a difference.

Side-effects are the 4^th leading cause of death in America:
2 Million Sick—106,000 Dead.  Imagine SAVING These Lives.
Doctors Call It An Historic Breakthrough

    JAMA reports that 2 million people have severe reactions to drugs every year—and 106,000 die. That’s 300 people a day, every single day. The airline industry losses 300 people a year due to crashes. It’s a national disgrace.

Plane crashes receive huge news coverage while drug deaths are almost invisible. Almost no one reports them. They quietly occur in private homes, emergency rooms and hospitals. They’re often mistaken for something else. The promise of Pharmacogenetics, or personalized medicine, is to help eliminate these terrible tragedies.

A Major Health Problem Is
  Solved Almost Instantly

It’s very big business. A single test like this can generate over $100 million dollars a year, according to Takeda Pacific, an international business consulting firm.

There’s more to this $4-a-share-wonder. A lot more…

Imagine Stopping One of the Most Feared Illnesses YEARS BEFORE You Have a Single Symptom. You Beat It At The Genetic Level

Going after some of the biggest diseases known to mankind, the company is developing diagnostic tests for cancer, neurodegenerative, cardiovascular, and infectious diseases, as well as pharmaco-genetics or tests for personalized medicine.

     It is also developing tests for genomic assays, including hyper-coagulation, warfarin metabolism, cystic fibrosis, herpes simplex virus, human papillomavirus, and respiratory virus panel; and protein assays, such as prostate specific antigen, cardiac troponin, and biomarker validation.

When I say “early detection,” most people don’t have a clue what I’m talking about. This is precisely why the brave new world our #1 small cap diagnostics stock is conquering is so revolutionary.  Their tests seek to detect these scary illnesses when they’re in their earliest stages—and by that I mean at the genetic level.

When you have such advance warning, your odds of surviving can go up ten-fold or more. Cancer, for example, is “curable” when caught at the early stages we now consider early—meaning it can be detected in a standard test or multiplex test.

This company gives our doctors even greater weapons to catch it way before then and their technology is available to virtually any laboratory in the world. Never in the history of mankind have we had this capability. It’s that new, that revolutionary and that effective. 

     Their patent portfolio is comprised, on a worldwide basis, of 80 issued patents and 150 pending patent applications, which, they either own directly or are the exclusive licensee.

The potential with these tests? Huge. The market is surging.

The Cancer Diagnostic Market Is Expected
To Hit $7.4 Billion In 2009

One Good Idea Can Make This Stock Rise Like Crazy.
Here’s Their Strategy…

            Their strategy for making money is shrewd.

     This stock can go up like you can’t believe based solely on the quality of their research alone. Huge drug companies will trip over themselves to get and pay for a great new idea, meaning buy the company. That’s because they’ll make even more money with their existing massive sales force, top brand recognition and unlimited marketing power.

     So the question becomes: how resourceful is management?

     The President and CEO has over 30 years experience in the diagnostics and medical devices industry and spent the last 20 developing novel technologies into products and solutions that have helped shape the industry and create shareholder value.

     But how profitable has his work and experience been?

     In his previous venture, he served as president and CEO for a developer, manufacturer and marketer of diagnostic products that pioneered the point-of-care blood analysis market.

This pioneer led them from its early stage to commercialization and then from the company's IPO in 1992 to its acquisition in 2003 for 5.18 times revenues or $392 million.

But it doesn’t stop there…

From 1973 through 1989 he held executive positions with a $7 billion manufacturer and distributor of healthcare products and a $3.5 billion diversified manufacturer and distributor of healthcare products.  

How about his team?

     The VP of Sales and Marketing and Chief Marketing Officer has more than 17 years of sales and marketing experience in the medical device industry.

Prior to his current position he spent 13 years of leadership roles in marketing and strategic development. Most recently, he served as the vice president of marketing, a $700 million division, of a $4.3 billion medical technology company.

Then there is the Vice President of International Sales and Marketing who has more than 21 years of healthcare experience in clinical diagnostics, medical devices and information technology with Fortune 500 companies such as Baxter, American Scientific Products, Allegiance Healthcare and two start-up technology companies.

Before joining the team in January 2002, he served as General Manager for Allegiance Healthcare with P&L responsibility for a $120 million revenue base.

It stuns me that this company is now only three dollars a share? I’m suggesting you climb aboard right NOW, because these gentlemen have done it before, and I’m convinced that they can do it again.

This Business Is NOT a Theory, It’s a Reality Right NOW…

            My first impression when researching this innovative and experienced company was this: all of this is probably 10 years away. It’s NOT. Everything you’ve read is here today. It’s a reality. That’s what I find so incredibly exciting. We’re talking about absolutely giant changes in the way we get and stay healthy.

When I say fortunes will be made, it’s true. A top researcher, Dr. Collins at a non-profit research Institute correctly says, “Oh my God, it’s unbelievable—the air is crackling,” That gives you a sense of the excitement.

NOW is the time to be in this booming industry—and this is the stock to own. Medicine is on the verge of changing forever. Those who don’t hesitate and recognize this opportunity can be richly rewarded. Look at what the experts say…

One of America’s Most Successful Investors
Advises You On Finding Winning Stocks

The Time To Act Is Now. I Can’t Promise
That I’ll Contact You Again

     What we have at hand is an extraordinary company with first-rate management. What amazes me is the fact that they’re just $3 a share.

I’m confident that once their profile is raised, like a bullet shot into the night sky, this one is going up like you can’t believe.

Actions Speak Louder Than Words

Alright, So what’s the name and ticker symbol of this amazing and mysterious company?

Well, as soon as you subscribe to Untapped Wealth, I’ll immediately send you everything you need to know about this stock that can turn a small $2,000 investment into $6,500 in a flash.

     You’ll instantly get the name of the company, the ticker symbol and a full report on how it alone may hold the key to the biggest breakthrough in healthcare since penicillin.

But remember, Piper Jaffrey has a $17 price target on it, so it could move up from $4 any moment, so the time to act is NOW!

You can join us now and get my free report.

But That’s Not All. Subscribe NOW and You’ll
Get A Treasure Trove of Research
Worth Over $495 -FREE!

Your First FREE Report:
“The Forever Battery: Making Today’s Batteries Obsolete… And It’s Investors Wildly Wealthy”

     In this FREE report you’ll discover the remarkable impact ONE simple advance can have on the global economy – and how getting it right means untold fortunes for a lucky few.

     Learn how the batteries you’re using now will become obsolete and how one misunderstood technology alone is responsible for producing a better, stronger, longer lasting battery.

A hint; the company’s proprietary technology enables the battery to remain dormant indefinitely…meaning it won’t lose juice until activated!

And of course (and most importantly) the name of the blockbuster little company that can catapult your wealth beyond anything you’ve ever imagined.

Your Second FREE Report:
WiMax: Transforming the Economic Landscape and Forging a New Breed of Millionaires

Invest alongside a multi-billionaire who founded one of America’s most successful technology companies. This is his latest venture that very, very few people know about. This fellow once counted Bill Gates, Chairman of Microsoft, as his business partner.

     If I were to tell you the company he founded, you’d instantly recognize it. Well, he’s back—and this time it could be more profitable then EVER. His plan is to use wireless broadband services to deliver SUPERFAST Internet connections over long distances. That’s a first!

You can’t miss this company.

Your Third FREE Report:
Geothermal Energy: The Secret Investment The Rich Are Flocking to.

     In this valuable report, you’ll discover a little-known stock that’s on the verge of becoming a major force in one of America’s least-known alternative energy sources: geothermal energy.

While solar and wind power are grabbing headlines, geothermal is making money right NOW.

Best of all, it’s competitive with any other energy source out there. According to the U.S. Department of Energy Report, they state that there’s been “a substantial surge in geothermal power projects in the U.S.” So investors are waking up to its immense potential.  

This company is experiencing record demand because geothermal power costs are PREDICTABLE and low.

This stock is under $10, but I believe the low seventies is where it can easily wind up.

Your Fourth FREE Report:
Radio Frequency Identification: How Microsoft Is Bringing RFID to the world and the one little company that they’re relying on to do it

In partnership with Microsoft, this low-profile enterprise develops, manufactures, and markets advanced-technology wireless systems that let anyone track almost anything. That’s much more important than it might first sound.

Tracking assets can improve profitability and cut costs like crazy. Once Wall Street better understands the hidden value here, the gains could top 500% in under 8 months.

Let’s say you own a trucking company. You can now schedule pickups with astounding precision because you know exactly where every truck is. Or maybe you work in the Homeland Security Department. Now you can track anything you think might be a threat. Does this work well? Take a look at their client list!

     Customers include Wal-Mart, 3M Company, American Axle, Archer Daniels Midland, Daimler- Chrysler, Deere & Co., Ford Motor Company, General Dynamics, Northrop Grumman, Target Corporation, Toyota, Walgreen Co., the U.S. Department of Homeland Security, the U.S. Navy, and the U.S. Postal Service, among many others.

Your Fifth FREE Report:
“Nanotechnology - How to Make $500,000 or More on This Disruptive Technology”

     I don’t think that the military has a choice when it comes to using nanotechnology. Never before has America faced so many able competitors and outright enemies. Many of them are well armed and growing in capability every day.

     The breakthroughs nanotechnology can offer us are unmatched by anything else. In one swift move, we pass our adversaries.

     In this free report, you’ll learn all about these miracles and how one exceptional stock could easily rise from $2.65 a share to $60.15.

But You Have to Remember to Act Immediately

Because once Wall Street gets a whiff of this tried and tested breadwinner, then the profits will launch into the sky like a NASA rocket ship!

All it takes in 1 more doctor to tell his friends, or one more science journal article or venture capitalist and this company is either taken over or moving to the moon, leaving early millionaires in it’s wake.

One More Important Thing…
 

Don’t miss this Urgent Buy Recommendation for the
 NUMBER ONE STOCK in the Genetic Diagnostics industry,
which ‘PROMISES TO REVOLUTIONIZE MEDICINE.’
 

I can’t promise you I’ll ever produce a better offer!
 

You can also Sign Up by dialing our toll free # 1-800-479-5084

Sincerely Yours,

Tim Fields
Editor-in-Chief
Untapped Wealth

           
P.S. It is the most critical and urgent medical field out there today, and as soon as this stock is discovered, you can kiss the $4 share price goodbye and say hello to at least $17 for starters…and it won’t stop there!

------------------------------------------- ORDER FORM -------------------------------------------

FREE Special Report: “Geothermal Energy - The Secret Investment the Ultra-Rich are Flocking to” FREE Special Report: “WiMax: Transforming The Economic Landscape... and Forging a New Breed of Millionaires” FREE Special Report: “How Microsoft is bringing RFID to the world… and the one little company their relying on to do it” FREE Special Report: “Nanotechnology - How to Make $500,000 or More on This Disruptive Technology” FREE Special Report: “The Forever Battery: Making Today's Batteries Obsolete... And Its Investors Wildly Wealthy”   FREE Web access to Untapped Wealth archives FREE Updates on Untapped open positions FREE Subscription to the Untapped Daily e-letter